Archive


Category: AAV Caspids

  • Sanofi Collaborates with Sirion to Develop Gene Therapy Treatment with Improved AAV Capsids

    Shots: The companies collaborated to develop improved tissue-selective AAV vectors to realize effective gene therapy treatments for multiple life-threatening disorders The focus of this agreement is to develop new and modified AAV capsids that exhibit a safe product profile with improved specificity and higher gene delivery efficiency The collaboration comes two years after Sirion signed […]